However, the study of the role of bazedoxifene in vascular biology and diseases is limited, and the mechanism by which bazedoxifene exerts its cardiovascular effects, particularly the extent to which the regulatory effect of bazedoxifene on CD40 levels alters ROS production to play a role in endothelial dysfunction, remains unclear. The gene discussed is CD40; the disease is endothelial dysfunction.